Clinical Trials Directory

Trials / Completed

CompletedNCT01398137

Ragweed Observational Study

An Observational Multi-Centre Field Study to Assess Symptom Scores and Rescue Medication Usage in Subjects With a History of Ragweed Allergen-Induced Rhinoconjunctivitis

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Circassia Limited · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is an observational to evaluate Total Rhinoconjunctivitis Symptom Score and rescue medication usage (as measured by Rescue Medication Score as a Combined Score to inform the design of a phase III field study with ToleroMune Ragweed.

Conditions

Timeline

Start date
2011-07-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2011-07-20
Last updated
2011-10-27

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01398137. Inclusion in this directory is not an endorsement.

Ragweed Observational Study (NCT01398137) · Clinical Trials Directory